185 related articles for article (PubMed ID: 29045940)
1. MiR-124 Attenuates Osteoclastogenic Differentiation of Bone Marrow Monocytes Via Targeting Rab27a.
Tang L; Yin Y; Liu J; Li Z; Lu X
Cell Physiol Biochem; 2017; 43(4):1663-1672. PubMed ID: 29045940
[TBL] [Abstract][Full Text] [Related]
2. miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway.
Zhao C; Sun W; Zhang P; Ling S; Li Y; Zhao D; Peng J; Wang A; Li Q; Song J; Wang C; Xu X; Xu Z; Zhong G; Han B; Chang YZ; Li Y
RNA Biol; 2015; 12(3):343-53. PubMed ID: 25826666
[TBL] [Abstract][Full Text] [Related]
3. Overexpressed miR-145 inhibits osteoclastogenesis in RANKL-induced bone marrow-derived macrophages and ovariectomized mice by regulation of Smad3.
Yu FY; Xie CQ; Sun JT; Peng W; Huang XW
Life Sci; 2018 Jun; 202():11-20. PubMed ID: 29577879
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-218 Negatively Regulates Osteoclastogenic Differentiation by Repressing the Nuclear Factor-κB Signaling Pathway and Targeting Tumor Necrosis Factor Receptor 1.
Wang W; Yang L; Zhang D; Gao C; Wu J; Zhu Y; Zhang H
Cell Physiol Biochem; 2018; 48(1):339-347. PubMed ID: 30016774
[TBL] [Abstract][Full Text] [Related]
5. The function of miR-218 and miR-618 in postmenopausal osteoporosis.
Wang WW; Yang L; Wu J; Gao C; Zhu YX; Zhang D; Zhang HX
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5534-5541. PubMed ID: 29271983
[TBL] [Abstract][Full Text] [Related]
6. miR-142-5p promotes the osteoclast differentiation of bone marrow-derived macrophages via PTEN/PI3K/AKT/FoxO1 pathway.
Lou Z; Peng Z; Wang B; Li X; Li X; Zhang X
J Bone Miner Metab; 2019 Sep; 37(5):815-824. PubMed ID: 30900017
[TBL] [Abstract][Full Text] [Related]
7. MiRNA-483-5p is involved in the pathogenesis of osteoporosis by promoting osteoclast differentiation.
Li K; Chen S; Cai P; Chen K; Li L; Yang X; Yi J; Luo X; Du Y; Zheng H
Mol Cell Probes; 2020 Feb; 49():101479. PubMed ID: 31706013
[TBL] [Abstract][Full Text] [Related]
8. miR-101-3p/Rap1b signal pathway plays a key role in osteoclast differentiation after treatment with bisphosphonates.
Li J; Li Y; Wang S; Che H; Wu J; Ren Y
BMB Rep; 2019 Sep; 52(9):572-576. PubMed ID: 31462380
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-506 upregulation contributes to sirtuin 1 inhibition of osteoclastogenesis in bone marrow stromal cells induced by TNF-α treatment.
Yan S; Miao L; Lu Y; Wang L
Cell Biochem Funct; 2019 Dec; 37(8):598-607. PubMed ID: 31515847
[TBL] [Abstract][Full Text] [Related]
10. mmu-miR-185 regulates osteoclasts differentiation and migration by targeting Btk.
He D; Jiao Y; Xu J; Luo J; Cui Y; Han X; Zhao H
J Gene Med; 2024 May; 26(5):e3687. PubMed ID: 38690623
[TBL] [Abstract][Full Text] [Related]
11. MiR-214 Attenuates Osteogenic Differentiation of Mesenchymal Stem Cells via Targeting FGFR1.
Yang L; Ge D; Cao X; Ge Y; Chen H; Wang W; Zhang H
Cell Physiol Biochem; 2016; 38(2):809-20. PubMed ID: 26872365
[TBL] [Abstract][Full Text] [Related]
12. circ_0029463 promotes osteoclast differentiation by mediating miR-134-5p/Rab27a axis.
Tang L; Yuan L; Yan J; Ge J; Lian Z; Li Z
J Orthop Surg Res; 2024 Feb; 19(1):128. PubMed ID: 38326867
[TBL] [Abstract][Full Text] [Related]
13. FTY720 inhibited proinflammatory cytokine release and osteoclastogenesis induced by Aggregatibacter actinomycetemcomitans.
Yu H; Herbert BA; Valerio M; Yarborough L; Hsu LC; Argraves KM
Lipids Health Dis; 2015 Jul; 14():66. PubMed ID: 26138336
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-338-3p inhibits glucocorticoid-induced osteoclast formation through RANKL targeting.
Zhang XH; Geng GL; Su B; Liang CP; Wang F; Bao JC
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706599
[TBL] [Abstract][Full Text] [Related]
15. MiR-1224-5p modulates osteogenesis by coordinating osteoblast/osteoclast differentiation via the Rap1 signaling target ADCY2.
Hu L; Xie X; Xue H; Wang T; Panayi AC; Lin Z; Xiong Y; Cao F; Yan C; Chen L; Cheng P; Zha K; Sun Y; Liu G; Yu C; Hu Y; Tao R; Zhou W; Mi B; Liu G
Exp Mol Med; 2022 Jul; 54(7):961-972. PubMed ID: 35831436
[TBL] [Abstract][Full Text] [Related]
16. A potential therapeutic target for regulating osteoporosis via suppression of osteoclast differentiation.
Sun Q; Zhang B; Zhu W; Wei W; Ma J; Tay FR
J Dent; 2019 Mar; 82():91-97. PubMed ID: 30716449
[TBL] [Abstract][Full Text] [Related]
17. miR-363-3p is activated by MYB and regulates osteoporosis pathogenesis via PTEN/PI3K/AKT signaling pathway.
Li M; Luo R; Yang W; Zhou Z; Li C
In Vitro Cell Dev Biol Anim; 2019 May; 55(5):376-386. PubMed ID: 31025251
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-155 inhibition up-regulates LEPR to inhibit osteoclast activation and bone resorption via activation of AMPK in alendronate-treated osteoporotic mice.
Mao Z; Zhu Y; Hao W; Chu C; Su H
IUBMB Life; 2019 Dec; 71(12):1916-1928. PubMed ID: 31317664
[TBL] [Abstract][Full Text] [Related]
19. miRNA-340 inhibits osteoclast differentiation via repression of MITF.
Zhao H; Zhang J; Shao H; Liu J; Jin M; Chen J; Huang Y
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28607030
[TBL] [Abstract][Full Text] [Related]
20. METTL14 represses osteoclast formation to ameliorate osteoporosis via enhancing GPX4 mRNA stability.
Deng M; Luo J; Cao H; Li Y; Chen L; Liu G
Environ Toxicol; 2023 Sep; 38(9):2057-2068. PubMed ID: 37195267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
